Concepts (206)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Calcitriol | 4 | 2015 | 32 | 1.510 |
Why?
|
| Vitamin D | 4 | 2015 | 196 | 1.210 |
Why?
|
| Cell Differentiation | 10 | 2015 | 638 | 1.080 |
Why?
|
| Transforming Growth Factor beta | 8 | 2008 | 216 | 1.060 |
Why?
|
| Myocytes, Cardiac | 3 | 2015 | 183 | 0.990 |
Why?
|
| Muscle Development | 4 | 2012 | 51 | 0.790 |
Why?
|
| Muscle, Skeletal | 10 | 2011 | 316 | 0.780 |
Why?
|
| Myostatin | 8 | 2011 | 61 | 0.610 |
Why?
|
| Vitamin D Deficiency | 2 | 2011 | 107 | 0.580 |
Why?
|
| Mesoderm | 3 | 2008 | 73 | 0.550 |
Why?
|
| Penis | 5 | 2019 | 90 | 0.470 |
Why?
|
| Muscle Fibers, Skeletal | 3 | 2012 | 70 | 0.470 |
Why?
|
| Cholecalciferol | 1 | 2014 | 20 | 0.430 |
Why?
|
| Heart | 1 | 2015 | 184 | 0.420 |
Why?
|
| Fibrosis | 3 | 2011 | 169 | 0.420 |
Why?
|
| Cardiovascular Diseases | 2 | 2011 | 749 | 0.390 |
Why?
|
| Gene Expression | 5 | 2012 | 701 | 0.380 |
Why?
|
| Mesenchymal Stem Cells | 2 | 2010 | 72 | 0.370 |
Why?
|
| Neovascularization, Physiologic | 1 | 2012 | 80 | 0.360 |
Why?
|
| Multipotent Stem Cells | 2 | 2010 | 16 | 0.360 |
Why?
|
| Cells, Cultured | 8 | 2019 | 1621 | 0.340 |
Why?
|
| Animals | 24 | 2019 | 16992 | 0.340 |
Why?
|
| Myoblasts | 2 | 2008 | 30 | 0.330 |
Why?
|
| Adipocytes | 3 | 2005 | 60 | 0.320 |
Why?
|
| Cell Shape | 1 | 2010 | 42 | 0.310 |
Why?
|
| Mice | 15 | 2012 | 6644 | 0.300 |
Why?
|
| Cell Proliferation | 3 | 2011 | 1455 | 0.300 |
Why?
|
| Cardiovascular System | 1 | 2009 | 37 | 0.300 |
Why?
|
| Cell Cycle | 1 | 2010 | 346 | 0.280 |
Why?
|
| Receptors, Androgen | 5 | 2008 | 144 | 0.270 |
Why?
|
| Collagen | 1 | 2008 | 181 | 0.270 |
Why?
|
| Piperazines | 3 | 2014 | 120 | 0.270 |
Why?
|
| Myocytes, Smooth Muscle | 2 | 2019 | 91 | 0.270 |
Why?
|
| Kidney Diseases | 1 | 2009 | 172 | 0.270 |
Why?
|
| Apoptosis | 3 | 2018 | 1568 | 0.260 |
Why?
|
| Receptors, Calcitriol | 3 | 2014 | 69 | 0.250 |
Why?
|
| Fibroblasts | 1 | 2008 | 281 | 0.240 |
Why?
|
| Testosterone | 5 | 2005 | 211 | 0.240 |
Why?
|
| Cell Line | 6 | 2012 | 1410 | 0.230 |
Why?
|
| Follistatin | 3 | 2008 | 28 | 0.210 |
Why?
|
| Health Status Disparities | 1 | 2011 | 719 | 0.210 |
Why?
|
| Cell Nucleus | 4 | 2014 | 383 | 0.200 |
Why?
|
| Mice, Inbred C3H | 4 | 2008 | 80 | 0.190 |
Why?
|
| Cyclic GMP | 2 | 2019 | 53 | 0.180 |
Why?
|
| Myosin Heavy Chains | 1 | 2002 | 18 | 0.180 |
Why?
|
| Recombinant Proteins | 4 | 2008 | 518 | 0.180 |
Why?
|
| Gene Expression Regulation | 5 | 2011 | 1070 | 0.180 |
Why?
|
| Citrulline | 2 | 2019 | 14 | 0.180 |
Why?
|
| Sulfones | 2 | 2012 | 47 | 0.170 |
Why?
|
| RNA, Messenger | 5 | 2012 | 1271 | 0.170 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2007 | 652 | 0.160 |
Why?
|
| Rats | 8 | 2018 | 3735 | 0.150 |
Why?
|
| Nitric Oxide | 2 | 2019 | 386 | 0.150 |
Why?
|
| Arginine | 1 | 2019 | 75 | 0.150 |
Why?
|
| MyoD Protein | 2 | 2011 | 9 | 0.150 |
Why?
|
| Signal Transduction | 6 | 2012 | 2157 | 0.140 |
Why?
|
| Dietary Supplements | 2 | 2011 | 213 | 0.140 |
Why?
|
| Olacaceae | 1 | 2018 | 2 | 0.140 |
Why?
|
| Paullinia | 1 | 2018 | 3 | 0.140 |
Why?
|
| Transforming Growth Factor beta1 | 2 | 2008 | 97 | 0.130 |
Why?
|
| Protein Transport | 3 | 2014 | 296 | 0.130 |
Why?
|
| RNA, Small Interfering | 3 | 2008 | 436 | 0.130 |
Why?
|
| beta Catenin | 2 | 2008 | 78 | 0.130 |
Why?
|
| Androgens | 2 | 2008 | 106 | 0.120 |
Why?
|
| Ganglia | 1 | 2014 | 12 | 0.110 |
Why?
|
| Sulfonamides | 1 | 2014 | 91 | 0.100 |
Why?
|
| Embryo, Mammalian | 1 | 2014 | 157 | 0.100 |
Why?
|
| Pluripotent Stem Cells | 2 | 2003 | 31 | 0.100 |
Why?
|
| Time Factors | 2 | 2008 | 1857 | 0.100 |
Why?
|
| Immunohistochemistry | 3 | 2005 | 934 | 0.100 |
Why?
|
| Fibroblast Growth Factor 1 | 1 | 2012 | 4 | 0.100 |
Why?
|
| Tissue Inhibitor of Metalloproteinase-3 | 1 | 2012 | 9 | 0.100 |
Why?
|
| Blotting, Western | 2 | 2007 | 883 | 0.090 |
Why?
|
| Ganglia, Autonomic | 1 | 2012 | 4 | 0.090 |
Why?
|
| Glial Cell Line-Derived Neurotrophic Factor Receptors | 1 | 2012 | 5 | 0.090 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 2012 | 45 | 0.090 |
Why?
|
| Glucocorticoids | 2 | 2003 | 91 | 0.090 |
Why?
|
| Organ Size | 3 | 2007 | 170 | 0.090 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2012 | 183 | 0.090 |
Why?
|
| Growth Differentiation Factors | 1 | 2011 | 7 | 0.090 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2011 | 28 | 0.090 |
Why?
|
| Insulin-Like Growth Factor II | 1 | 2011 | 25 | 0.090 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2011 | 60 | 0.090 |
Why?
|
| Disease Models, Animal | 3 | 2014 | 1596 | 0.080 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2012 | 300 | 0.080 |
Why?
|
| Vitamins | 1 | 2011 | 81 | 0.080 |
Why?
|
| Male | 14 | 2019 | 23409 | 0.080 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2011 | 100 | 0.080 |
Why?
|
| Genes, cdc | 1 | 2010 | 8 | 0.080 |
Why?
|
| Up-Regulation | 2 | 2014 | 536 | 0.080 |
Why?
|
| Extracellular Matrix | 1 | 2011 | 131 | 0.080 |
Why?
|
| GTP Phosphohydrolases | 1 | 2010 | 34 | 0.080 |
Why?
|
| rhoA GTP-Binding Protein | 1 | 2010 | 34 | 0.080 |
Why?
|
| TCF Transcription Factors | 2 | 2008 | 17 | 0.080 |
Why?
|
| Hypertrophy, Left Ventricular | 1 | 2009 | 45 | 0.080 |
Why?
|
| Neuroprotective Agents | 1 | 2012 | 269 | 0.070 |
Why?
|
| Rats, Sprague-Dawley | 4 | 2019 | 1766 | 0.070 |
Why?
|
| Transfection | 2 | 2007 | 532 | 0.070 |
Why?
|
| Nutrition Policy | 1 | 2009 | 64 | 0.070 |
Why?
|
| Bone Morphogenetic Protein 7 | 1 | 2008 | 6 | 0.070 |
Why?
|
| Matrix Metalloproteinase 8 | 1 | 2008 | 5 | 0.070 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2010 | 310 | 0.070 |
Why?
|
| Serpins | 1 | 2008 | 27 | 0.070 |
Why?
|
| Nerve Growth Factors | 1 | 2008 | 34 | 0.070 |
Why?
|
| Purines | 3 | 2014 | 40 | 0.070 |
Why?
|
| Oxidative Stress | 1 | 2014 | 1003 | 0.070 |
Why?
|
| Eye Proteins | 1 | 2008 | 63 | 0.070 |
Why?
|
| Smad Proteins | 1 | 2008 | 12 | 0.070 |
Why?
|
| Mice, Transgenic | 2 | 2007 | 665 | 0.070 |
Why?
|
| Mice, Inbred Strains | 1 | 2007 | 114 | 0.070 |
Why?
|
| Video Recording | 1 | 2007 | 41 | 0.060 |
Why?
|
| Rats, Inbred F344 | 3 | 2014 | 258 | 0.060 |
Why?
|
| Base Sequence | 2 | 2006 | 983 | 0.060 |
Why?
|
| Stroke Volume | 1 | 2007 | 122 | 0.060 |
Why?
|
| Heart Ventricles | 1 | 2007 | 123 | 0.060 |
Why?
|
| Gene Transfer Techniques | 1 | 2006 | 53 | 0.060 |
Why?
|
| Ethanol | 1 | 2008 | 224 | 0.060 |
Why?
|
| Risk Assessment | 1 | 2009 | 863 | 0.060 |
Why?
|
| Chronic Disease | 1 | 2009 | 549 | 0.060 |
Why?
|
| Humans | 7 | 2015 | 43102 | 0.060 |
Why?
|
| Down-Regulation | 1 | 2008 | 456 | 0.060 |
Why?
|
| Body Composition | 2 | 2003 | 159 | 0.060 |
Why?
|
| Nitric Oxide Synthase Type II | 2 | 2018 | 128 | 0.060 |
Why?
|
| Gene Expression Profiling | 1 | 2010 | 704 | 0.060 |
Why?
|
| Wnt Proteins | 1 | 2005 | 23 | 0.060 |
Why?
|
| Gestrinone | 1 | 2005 | 1 | 0.060 |
Why?
|
| Azacitidine | 1 | 2005 | 21 | 0.060 |
Why?
|
| Dexamethasone | 2 | 2003 | 55 | 0.060 |
Why?
|
| Cell Cycle Proteins | 1 | 2007 | 241 | 0.060 |
Why?
|
| Phenotype | 1 | 2008 | 780 | 0.060 |
Why?
|
| Androstenedione | 1 | 2004 | 19 | 0.060 |
Why?
|
| Phosphorylation | 1 | 2008 | 986 | 0.060 |
Why?
|
| Hypogonadism | 1 | 2004 | 23 | 0.060 |
Why?
|
| DNA Primers | 1 | 2005 | 294 | 0.050 |
Why?
|
| Adipose Tissue | 1 | 2005 | 182 | 0.050 |
Why?
|
| Dihydrotestosterone | 1 | 2003 | 28 | 0.050 |
Why?
|
| Muscular Atrophy | 1 | 2003 | 13 | 0.050 |
Why?
|
| Nerve Tissue | 2 | 2014 | 7 | 0.050 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 2002 | 31 | 0.050 |
Why?
|
| Blotting, Northern | 1 | 2002 | 150 | 0.050 |
Why?
|
| Subcellular Fractions | 1 | 2002 | 77 | 0.040 |
Why?
|
| Staining and Labeling | 1 | 2002 | 107 | 0.040 |
Why?
|
| Tissue Distribution | 1 | 2002 | 240 | 0.040 |
Why?
|
| Risk Factors | 1 | 2009 | 3994 | 0.040 |
Why?
|
| Transcription Factors | 1 | 2005 | 735 | 0.040 |
Why?
|
| United States | 1 | 2011 | 5205 | 0.040 |
Why?
|
| Cyclic Nucleotide Phosphodiesterases, Type 5 | 1 | 2019 | 8 | 0.040 |
Why?
|
| NG-Nitroarginine Methyl Ester | 1 | 2019 | 36 | 0.040 |
Why?
|
| Nitrites | 1 | 2019 | 55 | 0.040 |
Why?
|
| Muscle, Smooth | 1 | 2019 | 58 | 0.040 |
Why?
|
| Adult | 4 | 2009 | 13872 | 0.040 |
Why?
|
| Orchiectomy | 2 | 2008 | 37 | 0.030 |
Why?
|
| 3T3 Cells | 2 | 2005 | 64 | 0.030 |
Why?
|
| Penile Erection | 1 | 2014 | 26 | 0.030 |
Why?
|
| Heme Oxygenase-1 | 1 | 2014 | 52 | 0.030 |
Why?
|
| Reference Values | 2 | 2004 | 211 | 0.020 |
Why?
|
| Neurturin | 1 | 2012 | 2 | 0.020 |
Why?
|
| Pelvis | 1 | 2012 | 15 | 0.020 |
Why?
|
| Kinetics | 2 | 2004 | 695 | 0.020 |
Why?
|
| Nitric Oxide Synthase Type I | 1 | 2012 | 57 | 0.020 |
Why?
|
| Transforming Growth Factor beta2 | 1 | 2011 | 8 | 0.020 |
Why?
|
| Matrix Metalloproteinase 3 | 1 | 2011 | 16 | 0.020 |
Why?
|
| Matrix Metalloproteinase 1 | 1 | 2011 | 26 | 0.020 |
Why?
|
| Epidermal Growth Factor | 1 | 2011 | 70 | 0.020 |
Why?
|
| Cytokines | 1 | 2014 | 678 | 0.020 |
Why?
|
| Endothelium, Vascular | 1 | 2011 | 263 | 0.020 |
Why?
|
| Receptor Cross-Talk | 1 | 2008 | 18 | 0.020 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2008 | 20 | 0.020 |
Why?
|
| Lac Operon | 1 | 2006 | 21 | 0.020 |
Why?
|
| Electroporation | 1 | 2006 | 21 | 0.020 |
Why?
|
| Genes, Reporter | 1 | 2006 | 148 | 0.020 |
Why?
|
| Nerve Tissue Proteins | 1 | 2008 | 386 | 0.020 |
Why?
|
| Genetic Vectors | 1 | 2006 | 165 | 0.020 |
Why?
|
| Gene Silencing | 1 | 2006 | 154 | 0.010 |
Why?
|
| Plasmids | 1 | 2006 | 244 | 0.010 |
Why?
|
| Neurons | 1 | 2012 | 1263 | 0.010 |
Why?
|
| Biopsy, Needle | 1 | 2003 | 59 | 0.010 |
Why?
|
| Tosyl Compounds | 1 | 2003 | 4 | 0.010 |
Why?
|
| Muscle Proteins | 1 | 2003 | 51 | 0.010 |
Why?
|
| Anilides | 1 | 2003 | 28 | 0.010 |
Why?
|
| Androgen Antagonists | 1 | 2003 | 29 | 0.010 |
Why?
|
| Ligands | 1 | 2004 | 388 | 0.010 |
Why?
|
| Mifepristone | 1 | 2003 | 34 | 0.010 |
Why?
|
| Receptors, Glucocorticoid | 1 | 2003 | 35 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2008 | 1869 | 0.010 |
Why?
|
| Organ Specificity | 1 | 2003 | 141 | 0.010 |
Why?
|
| Nitriles | 1 | 2003 | 81 | 0.010 |
Why?
|
| Muscle Fibers, Fast-Twitch | 1 | 2002 | 7 | 0.010 |
Why?
|
| Muscle Fibers, Slow-Twitch | 1 | 2002 | 10 | 0.010 |
Why?
|
| Cell Division | 1 | 2003 | 311 | 0.010 |
Why?
|
| Anatomy, Cross-Sectional | 1 | 2002 | 10 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2005 | 592 | 0.010 |
Why?
|
| Stem Cells | 1 | 2003 | 152 | 0.010 |
Why?
|
| Hypertrophy | 1 | 2002 | 34 | 0.010 |
Why?
|
| Gonadotropin-Releasing Hormone | 1 | 2002 | 39 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2003 | 611 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 2002 | 317 | 0.010 |
Why?
|
| Adolescent | 2 | 2003 | 6081 | 0.010 |
Why?
|
| Body Weight | 1 | 2003 | 429 | 0.010 |
Why?
|
| Sex Factors | 1 | 2003 | 1028 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2003 | 1546 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2002 | 1124 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2002 | 587 | 0.010 |
Why?
|
| Child | 1 | 2003 | 3443 | 0.010 |
Why?
|
| Middle Aged | 1 | 2004 | 12222 | 0.000 |
Why?
|
| Female | 1 | 2003 | 24698 | 0.000 |
Why?
|